Further analysis using GEPIA exhibited that only TRIP13 was significantly associated with CRC survival, the reason for this might be that different inclusion criteria for high and low mRNA expression, clinical stages and pathological grading are applied in the prognosis analysis. This evidence concerns the gene TRIP13 and colorectal carcinoma.